Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Non-Current Assets (2020 - 2026)

Lucid Diagnostics filings provide 6 years of Non-Current Assets readings, the most recent being $3.0 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 46.52% to $3.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.4 million, a 25.23% decrease, with the full-year FY2025 number at $3.0 million, down 46.52% from a year prior.
  • Non-Current Assets hit $3.0 million in Q4 2025 for Lucid Diagnostics, down from $3.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $9.7 million in Q1 2022 to a low of $791812.0 in Q3 2021.
  • Median Non-Current Assets over the past 5 years was $5.7 million (2024), compared with a mean of $5.7 million.
  • Biggest five-year swings in Non-Current Assets: surged 977.15% in 2022 and later tumbled 46.52% in 2025.
  • Lucid Diagnostics' Non-Current Assets stood at $1.7 million in 2021, then skyrocketed by 380.72% to $8.2 million in 2022, then tumbled by 36.26% to $5.2 million in 2023, then grew by 7.12% to $5.6 million in 2024, then plummeted by 46.52% to $3.0 million in 2025.
  • The last three reported values for Non-Current Assets were $3.0 million (Q4 2025), $3.4 million (Q3 2025), and $4.8 million (Q2 2025) per Business Quant data.